4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4h-pyran has been researched along with camptothecin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, P; Wang, Z; Wu, H; Wu, S; Zeng, F | 1 |
1 other study(ies) available for 4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4h-pyran and camptothecin
| Article | Year |
|---|---|
A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Dendrimers; Drug Delivery Systems; Drug Design; Drug Liberation; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Optical Imaging; Prodrugs; Pyrans; Styrenes; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2017 |